Obesity: What impact on renal function?;Obésité: Quel impact sur la fonction rénale?

Revue Medicale Suisse

Volumn 2, Issue 55, 2006, Pages 576-581

  Mathieu, Claudine ^a   Teta, Daniel ^a   Vogt, Bruno ^a   Burnier, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADIPOSE TISSUE; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME INHIBITION; FOLLOW UP; GLOMERULOSCLEROSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; OBESITY; PROTEINURIA; SWITZERLAND; WEIGHT REDUCTION; KIDNEY; PATHOPHYSIOLOGY; REVIEW;

HUMANS; KIDNEY; KIDNEY DISEASES; OBESITY;

EID: 33748083391     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: 10.53738/revmed.2006.2.55.0576     Document Type: Article

References (44)

1. WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series No 894. Geneva:World Health Organisation, 2000.
2. Prentice AM.The emerging epidemic of obesity in developing countries. Int J Epidemiol Advance access published December 2,2005;doi:10.1093/ije/dyi272.
3. Flegal KM, Carrol MD, Kuczmarski RJ, et al. Overweight and obesity trends in the United States: Prevalence and trends, 1964-1994. Int J Obes Relat Metab Disord 1998;22:39-47.
4. Mokdad AH, Sedula MK, Dietz WH, et al. The spread of the obesity epidemic In the United States, 1991-1998. JAMA 1999;282:1519-22.
5. Office fédéral de la santé publique. Berne: OFSP, 2002.
6. Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: A complication of massive obesity. Ann Intern Med 1974;81:440-7.
7. Culleton BF, Larson MG, Parfrey PS, et al. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study. Am J Med 2000;109:1-8.
8. Grimm RH Jr, Svendsen KH, Kasiske B, et al. Proteinuria is a risk factor for mortality over IO years of follow-up. Multiple risk factor intervention trial. Kidney Int 1997;52(Suppl.63):S10-4.
9. Iseki K, Ikemiya Y, Iseki C, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;63:1468-74.
10. Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort Kidney Int 2004;65:1870-6.
11. Dornfeld L. Obesity, in Textbook of Nephroloy (2nd ed), edited by Glassock RJ, Massry SG. Baltimore: Williams and Wilkins, 1989;989-95.
12. Metcalf P, Baker J, Scott A, et al. Albuminuria in people at least 40 years old: Effect of obesity, hypertension and hyperlipidemia. Clin Chem 1992;38:1802-8.
13. Praga M, Hernandez E, Andres A, et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995;70:35-41.
14. Tozawa M, Iseki K, Kiseki C, et al. Influence of smoking and obesity on development of proteinuria. Kidney Int 2002;62:956-62.
15. Sakemi T, Toyoshima H, Morito F. Testosterone eliminates the attenuating effect of castration on progressive glomerular injury in hypercholesterolemic male Imai rats. Nephron 1994;76:469-76.
16. Praga M, Hernandez E, Herreo JC, et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephroectomy. Kidney Int 2000;58:2111-8.
17. Kasiske BL, Crosson JT Renal disease in patients with massive obesity. Arch Intern Med 1986;146:1105-9.
18. Bailey RR, Lynn KL, Burry AF, et al. Proteinuria, glomerulomegaly and focal segmental glomerulosclerosis in a grossly obese man with obstructive sleep apnea syndrome.Aust NAJ Med 1989;19:473-4.
19. Verani RR. Obesity associated focal segmental glomerulosclerosis: Pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 1992;20:629-34.
20. Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 2001;59:1498-509.
21. Praga M, Borstein B, Andres A, et al. Nephrotic proteinuria without hypoalbuminemia: Clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis 1991;17:330-8.
22. Praga MP, Morales E, Herrero JC, et al. Absence of hypoalbuminia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyper-filtration. Am J Kidney Dis 1999;33:52-8.
23. Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000;16:1790-8.
24. Bonnet F, Deprele C, Sassolas A, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2000;37:720-7.
25. Meier-Krische HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal translplant outcomes: A significant independent risk factor for graft failure and patient death.Transplantation 2002;73:70-4.
26. Bergstrom A, Hsieh CC, Lindblad R et al. Obesity and renal cell cancer: A quantitative review. Br J Cancer 2001;85:984-90.
27. Chow WH, Gridley G, Fraumeni JF, et al. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000;343:1305-11.
28. Hall JE, Crook ED, Jones DW, et al. Mechanism of obesity - associated cardiovascular and renal disease. Am J Med Sci 2002;324:127-37.
29. Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003;14:1480-6.
30. Juncos LA, Ito S. Disparate effects of insulin on isolated rabbit afferent and efferent arterioles. J Clin Invest 1993;92:1981-5.
31. Bickel CA, Verbalis JG, Knepper MA, et al. Increased renal Na-K-ATPase, NCC, and beta-EnaC abundance in obese Zucker rats. Am J Physiol Renal Physiol 2001;28l:F639-48.
32. Noda M, Matsuo T, Nagano-Tsuge H, et al. Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar fatty rats). Jpn J Pharmacol 2001;85:416-22.
33. Andersen PW, Zhang XY, Tian J, et al. Insulin and angiotensin II are additive in stimulating TGF-beta I and matrix mRNAs in mesangial cells. Kidney Int 1996;50:745-53.
34. Frystyyk J, Skjaerbaek C, Vesto E, et al. Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes. Diabetes Metab Res Rev 1999;15:314-22.
35. Fujiwara K, Hayashi K, Ozawa Y, et al. Renal protective effect of troglitazone in Wistar fatty rats. Metabolism 2000;49;1361-4.
36. Wolf G, Hammann A, Han DC, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cell: Potential role in glomerulosclerasis. Kidney Int 1999;56:860-72.
37. Han DC, Isono M, Chen S, et al. Leptin stimulates type I collagen production in db/db mesangial cells: Glucose uptake and TGF-beta type II receptor expression. Kidney Int 2001;59:1315-23.
38. Hall JE, Hidlbrandt DA, Kuo J. Obesity hypertension: Role of leptin and sympathetic nervous system. Am J Hyper-tens 2001;14:S103-15.
39. Keane WF. Lipids and the kidney. Kidney Int 1994;56:860-72.
40. Joles JA, Kunter U, Janssen U, et al. Early mechanism of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 2000;11:669-83.
41. Kasiske BL, O'Donnell MP, Cleary MP, et al. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988;33:667-72.
42. Sklar AH, Chaudhary BA. Reversible proteinuria in obstructive sleep apnea syndrome. Arch Intern Med 1988;148:87-9.
43. Hall JE, Kuo JJ, Da Silva AA, et al. Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 2003;12:195-200.
44. Henegar JR, Bigler SA, Henegar LK, et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001;12:1211-7.